Pharmaron brochure showcasing ocular testing services with scientific imagery, digital eye graphics, and a PDF download prompt.

Ocular Testing Services That Advance Therapeutic Development

Precision-Driven Preclinical Ocular Testing Services

At Pharmaron, our preclinical ocular services are designed to accelerate ophthalmic drug development by providing in-depth scientific insights, comprehensive test models, and advanced diagnostics. With validated in vivo and ex vivo models, we support small-molecule, biologic, cell, and gene therapy innovations targeting a wide range of ocular conditions.

Whether you’re developing treatments for retinal degeneration or assessing drug-eluting ocular implants, our testing services provide the translational relevance needed to make confident decisions early in your pipeline.

Unlocking Results with Purpose-Built Preclinical Ocular Efficacy Testing

Real-World Study Conditions. Quantifiable Outcomes:

Our preclinical ocular efficacy testing supports therapeutic programs for diseases affecting both the anterior and posterior segments. From wet and dry AMD to uveitis and diabetic retinopathy, Pharmaron’s models are optimized to mimic human pathophysiology.

Key Study Types:

  • Pharmacokinetics & Biodistribution – Quantitative tissue dissection and LC-MS/MS or ELISA analysis
  • Safety & Toxicology – Non-GLP and GLP studies including histopathology and clinical pathology
  • Ocular Efficacy Testing – Disease progression, healing, pain mitigation, neovascularization
  • Ex Vivo Permeability – Assays using cornea, conjunctiva, retina, vitreous, and more

Integrated, Species-Diverse Preclinical Ocular Testing Services

Broad Capabilities. Full Pipeline Support.

We work across a range of species, including mouse, rat, dog, pig, rabbit, and sheep, using tailored delivery routes like:

  • Intravitreal
  • Subconjunctival
  • Topical
  • Suprachoroidal
  • Subretinal

Pharmaron’s preclinical ocular services include high-resolution diagnostic tools such as:

  • OCT (30° and 55° lenses)
  • ERG & VEP
  • Slit-Lamp Biomicroscopy
  • Fundus Photography
  • IOP & Pachymetry
  • Specular & Ultrasound Imaging

Our team integrates drug delivery evaluation with pharmacological and functional endpoints, reducing time to decision and improving your confidence in compound selection.

Expanded Scope with Cell, Gene & Device Integration

Our facility is equipped for:

  • Cell & Gene Therapy Testing – Stem cell delivery, qPCR, IHC, in vivo tracking
  • Ocular Device Evaluation – Biocompatibility, contact lenses, IOLs, drug-eluting devices
  • CMC & Analytics – Non-GMP/GMP AAV and plasmid manufacturing, assay development

We support regulatory readiness with tailored analytics and reporting, providing you with actionable data without delay.

Why Partner with Pharmaron for Preclinical Ocular Services

  • Access to species-specific anatomical and physiological models
  • Optimized protocols for anterior and posterior delivery
  • Transparent, data-driven reporting
  • Cross-platform expertise in ocular devices, biologics, and cell/gene therapies

References:

Download the Full Brochure

Discover the full range of disease models, equipment, and service capabilities Pharmaron offers. Equip your team with the tools to make data-driven decisions faster.